NGeneBio’s genetic testing products for BRCA1 and BRCA2 mutations gained approval from Korea MFDS (Ministry of Food and Drug Safety)

Following the CE-IVD registration, We are proud to share that we have completed approval from South Korea for our genetic testing products ‘BRCAaccuTest™ PLUS’. BRCAaccuTest™ PLUS is a product that can analyze the BRCA1 and BRCA2 genes using NGS with high accuracy.

For the full Korean press release, head over to the below link.

㈜엔젠바이오, 유전성 유방암 및 난소암 NGS 진단제품 ‘BRCA아큐테스트 플러스‘ 식약처 3등급 허가 취득

August 23, 2021 @South Korea